Neslihan Cicek1, Harika Alpay2, Sercin Guven2, Ceren Alavanda3, Özde Nisa Türkkan2, Serim Pul2, Ece Demirci2, Nurdan Yıldız2, Pınar Ata3, Ibrahim Gokce2. 1. Department of Pediatric Nephrology, Marmara University School of Medicine, Fevzi Çakmak Mahallesi Muhsin Yazıcıoğlu Caddesi No: 10, Ust Kaynarca/Pendik, Istanbul, Turkey. drneslihancicek@yahoo.com. 2. Department of Pediatric Nephrology, Marmara University School of Medicine, Fevzi Çakmak Mahallesi Muhsin Yazıcıoğlu Caddesi No: 10, Ust Kaynarca/Pendik, Istanbul, Turkey. 3. Department of Medical Genetics, Marmara University School of Medicine, Fevzi Çakmak Mahallesi Muhsin Yazıcıoğlu Caddesi No: 10, Ust Kaynarca/Pendik, Istanbul, Turkey.
Abstract
BACKGROUND: Cubilin is one of the receptor proteins responsible for reabsorption of albumin in proximal tubules and is encoded by the CUBN gene. We aimed to evaluate clinical and genetic characterization of six patients with proteinuria who had CUBN mutations. METHODS: Patients' characteristics, serum creatinine, albumin, vitamin B12 levels, urine analysis, spot urine protein/creatinine, microalbumin/creatinine, beta-2 microglobulin/creatinine ratios, estimated glomerular filtration rates (eGFR), treatments, kidney biopsies, and genetic analyses were evaluated. RESULTS: Six patients (2 female, 4 male) with an incidental finding of proteinuria were evaluated. Mean admission age and follow-up time were 7.3 ± 2.9 and 6.5 ± 5.6 years, respectively. Serum albumin, creatinine, and eGFR were normal; urine analysis revealed no hematuria, and C3, C4, ANA, and anti-DNA were negative; kidney ultrasonography was normal for all patients. Urine protein/creatinine was 0.9 ± 0.3 mg/mg, and microalbumin was high in all patients. Serum vitamin B12 was low in two patients and normal in four. Kidney biopsy was performed in four patients, three demonstrated normal light microscopy, and there was one focal segmental glomerulosclerosis (FSGS). Genetic tests revealed four homozygous and two compound heterozygous mutations in the C-terminal part of cubilin. All patients had normal eGFR and still had non-nephrotic range proteinuria at last visit. CONCLUSIONS: CUBN gene mutations should be considered in patients with isolated non-nephrotic range proteinuria and normal kidney function. Diagnosing these patients, who are thought to have a better prognosis, is important in terms of avoiding unnecessary treatment and predicting prognosis. CUBN gene mutations may also present as FSGS which extends the spectrum of renal manifestation of these patients. A higher resolution version of the Graphical abstract is available as Supplementary information.
BACKGROUND: Cubilin is one of the receptor proteins responsible for reabsorption of albumin in proximal tubules and is encoded by the CUBN gene. We aimed to evaluate clinical and genetic characterization of six patients with proteinuria who had CUBN mutations. METHODS: Patients' characteristics, serum creatinine, albumin, vitamin B12 levels, urine analysis, spot urine protein/creatinine, microalbumin/creatinine, beta-2 microglobulin/creatinine ratios, estimated glomerular filtration rates (eGFR), treatments, kidney biopsies, and genetic analyses were evaluated. RESULTS: Six patients (2 female, 4 male) with an incidental finding of proteinuria were evaluated. Mean admission age and follow-up time were 7.3 ± 2.9 and 6.5 ± 5.6 years, respectively. Serum albumin, creatinine, and eGFR were normal; urine analysis revealed no hematuria, and C3, C4, ANA, and anti-DNA were negative; kidney ultrasonography was normal for all patients. Urine protein/creatinine was 0.9 ± 0.3 mg/mg, and microalbumin was high in all patients. Serum vitamin B12 was low in two patients and normal in four. Kidney biopsy was performed in four patients, three demonstrated normal light microscopy, and there was one focal segmental glomerulosclerosis (FSGS). Genetic tests revealed four homozygous and two compound heterozygous mutations in the C-terminal part of cubilin. All patients had normal eGFR and still had non-nephrotic range proteinuria at last visit. CONCLUSIONS: CUBN gene mutations should be considered in patients with isolated non-nephrotic range proteinuria and normal kidney function. Diagnosing these patients, who are thought to have a better prognosis, is important in terms of avoiding unnecessary treatment and predicting prognosis. CUBN gene mutations may also present as FSGS which extends the spectrum of renal manifestation of these patients. A higher resolution version of the Graphical abstract is available as Supplementary information.
Authors: M Aminoff; J E Carter; R B Chadwick; C Johnson; R Gräsbeck; M A Abdelaal; H Broch; L B Jenner; P J Verroust; S K Moestrup; A de la Chapelle; R Krahe Journal: Nat Genet Date: 1999-03 Impact factor: 38.330
Authors: H Birn; J C Fyfe; C Jacobsen; F Mounier; P J Verroust; H Orskov; T E Willnow; S K Moestrup; E I Christensen Journal: J Clin Invest Date: 2000-05 Impact factor: 14.808
Authors: Sabine Amsellem; Jakub Gburek; Ghislaine Hamard; Rikke Nielsen; Thomas E Willnow; Olivier Devuyst; Ebba Nexo; Pierre J Verroust; Erik I Christensen; Renata Kozyraki Journal: J Am Soc Nephrol Date: 2010-08-26 Impact factor: 10.121
Authors: George J Schwartz; Alvaro Muñoz; Michael F Schneider; Robert H Mak; Frederick Kaskel; Bradley A Warady; Susan L Furth Journal: J Am Soc Nephrol Date: 2009-01-21 Impact factor: 10.121
Authors: Carsten A Böger; Ming-Huei Chen; Adrienne Tin; Matthias Olden; Anna Köttgen; Ian H de Boer; Christian Fuchsberger; Conall M O'Seaghdha; Cristian Pattaro; Alexander Teumer; Ching-Ti Liu; Nicole L Glazer; Man Li; Jeffrey R O'Connell; Toshiko Tanaka; Carmen A Peralta; Zoltán Kutalik; Jian'an Luan; Jing Hua Zhao; Shih-Jen Hwang; Ermeg Akylbekova; Holly Kramer; Pim van der Harst; Albert V Smith; Kurt Lohman; Mariza de Andrade; Caroline Hayward; Barbara Kollerits; Anke Tönjes; Thor Aspelund; Erik Ingelsson; Gudny Eiriksdottir; Lenore J Launer; Tamara B Harris; Alan R Shuldiner; Braxton D Mitchell; Dan E Arking; Nora Franceschini; Eric Boerwinkle; Josephine Egan; Dena Hernandez; Muredach Reilly; Raymond R Townsend; Thomas Lumley; David S Siscovick; Bruce M Psaty; Bryan Kestenbaum; Talin Haritunians; Sven Bergmann; Peter Vollenweider; Gerard Waeber; Vincent Mooser; Dawn Waterworth; Andrew D Johnson; Jose C Florez; James B Meigs; Xiaoning Lu; Stephen T Turner; Elizabeth J Atkinson; Tennille S Leak; Knut Aasarød; Frank Skorpen; Ann-Christine Syvänen; Thomas Illig; Jens Baumert; Wolfgang Koenig; Bernhard K Krämer; Olivier Devuyst; Josyf C Mychaleckyj; Cosetta Minelli; Stephan J L Bakker; Lyudmyla Kedenko; Bernhard Paulweber; Stefan Coassin; Karlhans Endlich; Heyo K Kroemer; Reiner Biffar; Sylvia Stracke; Henry Völzke; Michael Stumvoll; Reedik Mägi; Harry Campbell; Veronique Vitart; Nicholas D Hastie; Vilmundur Gudnason; Sharon L R Kardia; Yongmei Liu; Ozren Polasek; Gary Curhan; Florian Kronenberg; Inga Prokopenko; Igor Rudan; Johan Arnlöv; Stein Hallan; Gerjan Navis; Afshin Parsa; Luigi Ferrucci; Josef Coresh; Michael G Shlipak; Shelley B Bull; Nicholas J Paterson; H-Erich Wichmann; Nicholas J Wareham; Ruth J F Loos; Jerome I Rotter; Peter P Pramstaller; L Adrienne Cupples; Jacques S Beckmann; Qiong Yang; Iris M Heid; Rainer Rettig; Albert W Dreisbach; Murielle Bochud; Caroline S Fox; W H L Kao Journal: J Am Soc Nephrol Date: 2011-03 Impact factor: 14.978
Authors: Lisa Gianesello; Giovanna Priante; Monica Ceol; Claudia M Radu; Moin A Saleem; Paolo Simioni; Liliana Terrin; Franca Anglani; Dorella Del Prete Journal: Sci Rep Date: 2017-10-20 Impact factor: 4.379